» Articles » PMID: 21242963

Identification of a Progenitor Cell of Origin Capable of Generating Diverse Meningioma Histological Subtypes

Overview
Journal Oncogene
Date 2011 Jan 19
PMID 21242963
Citations 65
Authors
Affiliations
Soon will be listed here.
Abstract

Meningiomas are among the most common primary central nervous system tumours in adults. Studies focused on the molecular basis for meningioma development are hampered by a lack of information with regard to the cell of origin for these brain tumours. Herein, we identify a prostaglandin D synthase-positive meningeal precursor as the cell of origin for murine meningioma, and show that neurofibromatosis type 2 (Nf2) inactivation in prostaglandin D2 synthase (PGDS) (+) primordial meningeal cells, before the formation of the three meningeal layers, accounts for the heterogeneity of meningioma histological subtypes. Using a unique PGDSCre strain, we define a critical embryonic and early postnatal developmental window in which biallelic Nf2 inactivation in PGDS (+) progenitor cells results in meningioma formation. Moreover, we identify differentially expressed markers that characterize the two major histological meningioma subtypes both in human and mouse tumours. Collectively, these findings establish the cell of origin for these common brain tumours as well as a susceptible developmental period in which signature genetic mutations culminate in meningioma formation.

Citing Articles

A novel compound, SYHA1813, inhibits malignant meningioma growth directly by boosting p53 pathway activation and impairing DNA repair.

Lan Y, Li S, Wang J, Yang X, Wang C, Huang M Front Oncol. 2025; 15:1522249.

PMID: 40052125 PMC: 11882425. DOI: 10.3389/fonc.2025.1522249.


Cas9 Mouse Model of Skull Base Meningioma Driven by Combinational Gene Inactivation in Meningeal Cells.

Tang H, Xu F, Sun D, Hua L, Xiong J, Xu M CNS Neurosci Ther. 2025; 31(2):e70287.

PMID: 39996452 PMC: 11851153. DOI: 10.1111/cns.70287.


Molecular biomarkers in meningioma (Review).

Dwianingsih E, Krisnugraha Y, Bawono R, Malueka R Biomed Rep. 2025; 22(4):56.

PMID: 39991008 PMC: 11843207. DOI: 10.3892/br.2025.1934.


A case of multiples liver metastases from a grade 2 brain meningioma: a rare entity with comprehensive literature review.

Borni M, Kammoun B, Taallah M, Mzid Y, Boudawara O, Boudawara M Ann Med Surg (Lond). 2024; 86(9):5631-5638.

PMID: 39239057 PMC: 11374259. DOI: 10.1097/MS9.0000000000002460.


Targeting histone deacetylase 6 (HDAC6) to enhance radiation therapy in meningiomas in a 2D and 3D in vitro study.

Na J, Shaji S, Hanemann C EBioMedicine. 2024; 105:105211.

PMID: 38917510 PMC: 11255518. DOI: 10.1016/j.ebiom.2024.105211.